Literature DB >> 21932010

A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5.

Takayuki Okamoto1, Toshihiro Tajima, Tomoya Hirayama, Satoshi Sasaki.   

Abstract

UNLABELLED: Dent disease is an X-linked tubulopathy mainly caused by inactivating mutations of CLCN5. Features of Bartter syndrome such as hypokalemic metabolic alkalosis are rarely observed in patients with Dent disease. We report a Japanese male patient with Dent disease who also manifested features of Bartter syndrome. At the age of 3 years, he was diagnosed with Dent disease based on low molecular weight proteinuria and hypercalciuria. One year later, he was found to have features of Bartter syndrome, i.e., hypokalemia and metabolic alkalosis, and high levels of plasma renin activity and aldosterone with a normal blood pressure. Despite medical interventions, he developed chronic kidney disease stage 3 at the age of 21 years. To investigate the molecular basis of his disease, CLCN5, KCNJ1, SLC12A1, and CLCkb were analyzed and a novel mutation (Y567X) in CLCN5 was identified.
CONCLUSION: Hypokalemic metabolic alkalosis is a rare manifestation in Dent disease. It is speculated that Dent patients with features of Bartter syndrome are susceptible to progression to renal failure. To study this hypothesis, additional observations and long-term follow-up of such patients are necessary.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21932010     DOI: 10.1007/s00431-011-1578-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  CLCN5 mutation (R347X) associated with hypokalaemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent's disease.

Authors:  Nesrin Besbas; Fatih Ozaltin; Nikola Jeck; Hannsjörg Seyberth; Michael Ludwig
Journal:  Nephrol Dial Transplant       Date:  2005-04-06       Impact factor: 5.992

2.  Phenotypic and genetic heterogeneity in Dent's disease--the results of an Italian collaborative study.

Authors:  Enrica Tosetto; Gian Marco Ghiggeri; Francesco Emma; Giancarlo Barbano; Alba Carrea; Giuseppe Vezzoli; Rossella Torregrossa; Marilena Cara; Gabriele Ripanti; Anita Ammenti; Licia Peruzzi; Luisa Murer; Ilse Maria Ratsch; Lorenzo Citron; Giovanni Gambaro; Angela D'angelo; Franca Anglani
Journal:  Nephrol Dial Transplant       Date:  2006-07-05       Impact factor: 5.992

3.  Focal segmental glomerulosclerosis in a boy with Dent-2 disease.

Authors:  Kazunari Kaneko; Masafumi Hasui; Atsuko Hata; Daisuke Hata; Kandai Nozu
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

4.  A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency.

Authors:  Radovan Bogdanović; Markus Draaken; Alma Toromanović; Maja Dordević; Natasa Stajić; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2010-08-01       Impact factor: 3.714

5.  Influence of upright activity on plasma renin activity and aldosterone concentration in children.

Authors:  J Fukushige; K Shimomura; K Ueda
Journal:  Eur J Pediatr       Date:  1994-04       Impact factor: 3.183

6.  Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome.

Authors:  A D Schachter; G S Arbus; R J Alexander; J W Balfe
Journal:  Pediatr Nephrol       Date:  1998-11       Impact factor: 3.714

7.  Growth hormone improves growth rate and preserves renal function in Dent disease.

Authors:  Sharone Sheffer-Babila; Manju Chandra; Phyllis W Speiser
Journal:  J Pediatr Endocrinol Metab       Date:  2008-03       Impact factor: 1.634

8.  Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis.

Authors:  Lawrence Copelovitch; Martin A Nash; Bernard S Kaplan
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-08       Impact factor: 8.237

9.  Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis.

Authors:  Hajime Yamazaki; Kandai Nozu; Ichiei Narita; Michio Nagata; Yoshimi Nozu; Xue Jun Fu; Masafumi Matsuo; Kazumoto Iijima; Fumitake Gejyo
Journal:  Pediatr Nephrol       Date:  2008-10-02       Impact factor: 3.714

10.  Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules.

Authors:  Erik I Christensen; Olivier Devuyst; Geneviève Dom; Rikke Nielsen; Patrick Van der Smissen; Pierre Verroust; Michèle Leruth; William B Guggino; Pierre J Courtoy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  13 in total

1.  Growth hormone therapy for a patient with idiopathic Fanconi syndrome and growth hormone deficiency.

Authors:  Takayuki Okamoto; Yasuyuki Sato; Takeshi Yamazaki; Asako Hayashi; Toshiyuki Takahashi
Journal:  CEN Case Rep       Date:  2017-02-09

2.  A novel CLCN5 mutation in a Chinese boy with Dent's disease.

Authors:  Li-Na Ji; Chao-Ying Chen; Jing-Jing Wang; Li Cao
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

Review 3.  Genomic medicine for kidney disease.

Authors:  Emily E Groopman; Hila Milo Rasouly; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2018-01-08       Impact factor: 28.314

Review 4.  Nephrolithiasis secondary to inherited defects in the thick ascending loop of henle and connecting tubules.

Authors:  Nicolas Faller; Nasser A Dhayat; Daniel G Fuster
Journal:  Urolithiasis       Date:  2018-11-20       Impact factor: 3.436

Review 5.  The expanding phenotypic spectra of kidney diseases: insights from genetic studies.

Authors:  Marijn F Stokman; Kirsten Y Renkema; Rachel H Giles; Franz Schaefer; Nine V A M Knoers; Albertien M van Eerde
Journal:  Nat Rev Nephrol       Date:  2016-07-04       Impact factor: 28.314

6.  Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene.

Authors:  Eleni Drosataki; Sevasti Maragkou; Kleio Dermitzaki; Ioanna Stavrakaki; Dimitra Lygerou; Helen Latsoudis; Christos Pleros; Ioannis Petrakis; Ioannis Zaganas; Kostas Stylianou
Journal:  BMC Nephrol       Date:  2022-05-12       Impact factor: 2.585

7.  Barttin Regulates the Subcellular Localization and Posttranslational Modification of Human Cl-/H+ Antiporter ClC-5.

Authors:  Daniel Wojciechowski; Elena Kovalchuk; Lan Yu; Hua Tan; Christoph Fahlke; Gabriel Stölting; Alexi K Alekov
Journal:  Front Physiol       Date:  2018-10-23       Impact factor: 4.566

Review 8.  Proteinuria in Dent disease: a review of the literature.

Authors:  Youri van Berkel; Michael Ludwig; Joanna A E van Wijk; Arend Bökenkamp
Journal:  Pediatr Nephrol       Date:  2016-10-18       Impact factor: 3.714

Review 9.  Dent disease: A window into calcium and phosphate transport.

Authors:  Franca Anglani; Lisa Gianesello; Lada Beara-Lasic; John Lieske
Journal:  J Cell Mol Med       Date:  2019-08-31       Impact factor: 5.310

Review 10.  Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon.

Authors:  Lisa Gianesello; Dorella Del Prete; Franca Anglani; Lorenzo A Calò
Journal:  Hum Genet       Date:  2020-08-29       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.